INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
FJ

Fitzpatrick Jennifer

Chief Legal OfficerCIK 0002061851

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 3
Max Insider Score23
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A—
28.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Sionna Therapeutics, Inc.Chief Legal Officer · Dec 9, 2025
17
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A
—
28.1K sh
Sep 17, 2026
Sep 18, 2026
traded Sep 17, 2026
+1d
SEC FORM 4

Evidence

5
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Disposition to issuer
D—
103.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

5
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A—
103.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

3
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.3K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

19
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$447K
10.3K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

0
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
10.3K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

19
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$347K
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC FORM 4

Evidence

0
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC FORM 4

Evidence

3
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC FORM 4

Evidence

5
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Grant or award
A—
103.1K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

23
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$415K
10.3K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

2
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
10.3K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

7
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.3K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence